论文部分内容阅读
2000-2004年期间,Bayer将投入51亿美元用于其在美国的研究与开发方面的费用支出。其中,常用保健药品、临床诊断用品和医药品将作为重点开发领域。
During the period 2000-2004, Bayer will invest $5.1 billion for its research and development expenses in the United States. Among them, commonly used health medicines, clinical diagnostic products and pharmaceuticals will be the key development areas.